Antisense: a key tool for cell and developmental studies in Dictyostelium

Cell motility mediates tissue size regulation in Dictyostelium

Little is known about how organisms regulate the size of multicellular structures. This review condenses some of the observations about how Dictyostelium regulates the size of fruiting bodies. Very large fruiting bodies tend to fall over, and one of the ways Dictyostelium cells prevent this is by breaking up the aggregation streams when there is an excessive number of cells in the stream. Developing cells simultaneously secrete and sense counting factor (CF), a 450 kDa complex of proteins. Diffusion calculations showed that as the number of cells in a stream or group increases, the local concentration of CF will increase, allowing the cells to sense the number of cells in the stream or group. Computer simulations predicted that a high level of CF could trigger stream breakup by decreasing cell-cell adhesion and/or increasing cell motility, effectively causing the stream to dissipate and begin to fall apart. The prediction that adhesion and motility affect group size is supported by observations that decreasing adhesion by adding antibodies that bind to adhesion protein causes the formation of smaller groups, while increasing adhesion by overexpressing adhesion proteins, or decreasing motility with drugs that disrupt actin function both cause the formation of larger groups. CF both decreases adhesion and increases motility. CF increases motility in part by increasing actin polymerization and myosin phosphorylation, and decreasing myosin polymerization. New observations using a fusion of a green fluorescent protein to a protein fragment that binds polymerized actin show that in live cells CF does not affect the distribution of polymerized actin. CF increases the levels of ABP-120, an actin-bundling protein, and new observations indicate that very low levels of CF cause an increase in levels of myoB, an unconventional myosin. Our current understanding of group size regulation in Dictyostelium is thus that motility plays a key role, and that to regulate group size cells regulate the expression of at least two proteins, as well as regulating the polymerization of both actin and myosin.

Functional genomics approaches for the identification and validation of antifungal drug targets

So far, antifungal drug discovery seems to have benefited little from the enormous advances in the field of genomics in the last decade. Although it has become clear that traditional drug screening is not delivering the long-awaited novel potent antifungals, little has been reported on efforts to use novel genome-based methodologies in the quest for new drugs acting on human pathogenic fungi. Although the market for a novel systemic and even topical broad-spectrum antifungal appears considerable, many large pharmaceutical companies have decided to scale back their activities in antifungal drug discovery. Here we report on some of the recent advances in genomics-based technologies that will allow us not only to identify and validate novel drug targets but hopefully also to discover active therapeutic agents. Novel drug targets have already been found by 'en masse' gene inactivation strategies (e.g. using antisense RNA inhibition). In addition, genome expression profiling using DNA microarrays helps to assign gene function but also to understand better the mechanism of action of known drugs (e.g. itraconazole) and to elucidate how new drug candidates work. No doubt, we have a long way to go just to catch up with the advances made in other therapeutic areas, but all tools are at hand to derive practical benefits from the genomics revolution. The next few years should prove a very exciting time in the history of antifungal drug discovery.

RNA-mediated gene silencing in non-pathogenic and pathogenic fungi

Many fungal genomes have now been sequenced and thousands of genes are being discovered. Gene disruption or inactivation technology offers an important tool not only for elucidating the function of the many unknown genes but also for the identification of genes essential for fungal growth and pathogenesis. A variety of gene-silencing methods that inhibit genes at the post-transcriptional level are now being used in both non-pathogenic and human pathogenic fungi. We focus on the recent advances in RNA-mediated gene silencing technologies and their potential for functional genomics studies in fungi.

Regulation of cell-fate determination in Dictyostelium

A key step in the development of all multicellular organisms is the differentiation of specialized cell types. The eukaryotic microorganism Dictyostelium discoideum provides a unique experimental system for studying cell-type determination and spatial patterning in a developing multicellular organism. Unlike metazoans, which become multicellular by undergoing many rounds of cell division after fertilization of an egg, the social amoeba Dictyostelium achieves multicellularity by the aggregation of approximately 10(5) cells in response to nutrient depletion. Following aggregation, cell-type differentiation and morphogenesis result in a multicellular organism with only a few cell types that exhibit a defined patterning along the anterior-posterior axis of the organism. Analysis of the mechanisms that control these processes is facilitated by the relative simplicity of Dictyostelium development and the availability of molecular, genetic, and cell biological tools. Interestingly, analysis has shown that many molecules that play integral roles in the development of higher eukaryotes, such as PKA, STATs, and GSK-3, are also essential for cell-type differentiation and patterning in Dictyostelium. The role of these and other signaling pathways in the induction, maintenance, and patterning of cell types during Dictyostelium development is discussed.

Genomes and proteomes: towards a multidimensional view of biology

The third Siena proteomics conference held August 31-September 4, 1998, heralded a change in emphasis from technology development to using proteomics to assist in resolving biological questions. In this review, proteomics is placed in context with other major influences in the way discovery research is conducted in biology. The current status of genomics is examined in its broadest sense, including how such studies may influence the development of proteomics. It is suggested that we are entering a new phase in biology where information is no longer limiting and integration of different technologies is required to attack the big problems of biology. While much of the focus of funding bodies, both in the public and private sector, is on practical outcomes (new drugs, etc.), the new technologies are equally amenable to attacking long-standing fundamental challenges, such as cell division, cell patterning and morphogenesis.